MedPath

EMST and TMS for Treatment of Dysphagia in Parkinson's Disease

Not Applicable
Completed
Conditions
Parkinson's Disease
Registration Number
NCT02461082
Lead Sponsor
University Hospital Muenster
Brief Summary

The purpose of the study is to examine the effectiveness of different methods for the treatment of dysphagia in Parkinson's disease (PD). More than 80% of patients suffering from PD develop dysphagia during the course of their disease leading to malnutrition, loss of life quality, weight loss and pneumonia, which is the leading cause of death in these patients. So far, only a few specific treatment approaches have been investigated in PD patients with swallowing disorders. The investigator want to compare a 4-week expiratory muscle strength training (EMST), transcranial magnetic stimulation (TMS), and combination of both with a sham therapy. Dysphagia severity before and after intervention is measured by flexible endoscopic evaluation of swallowing (FEES). For the evaluation of changes in cortical swallowing processing the investigators apply magnetoencephalography (MEG).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
53
Inclusion Criteria
  • Hoehn & Yahr stages II-IV
  • Parkinson-related dysphagia
  • Oral nutrition
  • Ambulant setting
  • No change of medication for at least 4 weeks before study inclusion
Exclusion Criteria
  • Other causes for dysphagia
  • Other neurological disease potentially causing dysphagia
  • Dementia (MMSE<25; Montreal cognitive assessment (MoCA)<26)
  • Severe depression (BDI>19)
  • Percutaneous endoscopic gastrostomy (PEG)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Dysphagia severity as measured by FEESFour weeks
Secondary Outcome Measures
NameTimeMethod
Dysphagia severity as measured by FEESThree month
Cortical reorganization of swallowing process as detected by MEGFour weeks and three month
Changes in quality of life as measured by the swallowing quality of life questionnaire (Swal-Qol)Four weeks and three months

Trial Locations

Locations (1)

Department of neurology, University Hospital of Muenster

🇩🇪

Muenster, Nordrhein-Westfalen, Germany

Department of neurology, University Hospital of Muenster
🇩🇪Muenster, Nordrhein-Westfalen, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.